Bioengineered Skin Sealants
生物工程皮肤密封剂
基本信息
- 批准号:10457977
- 负责人:
- 金额:$ 37.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAgonistAnimalsAnti-Bacterial AgentsAreaBindingBiochemicalBiologicalBiological AssayBiomechanicsBiomedical EngineeringBiopsyCharacteristicsCicatrixClinicalColony-forming unitsCommunity HospitalsConsumptionCorrelation StudiesCyanoacrylatesDermabondDermalDrug Delivery SystemsDrug or chemical Tissue DistributionDrug usageDyesEvaluationExcisionFibrinFormulationGluesGoldHeterogeneityHistamine ReceptorHistologyHistopathologyHumanImageImmunocompetentImmunohistochemistryIn VitroInbred BALB C MiceIndocyanine GreenInfectionInfection ControlInvestigationInvestigational TherapiesLacerationLasersLeadLesionLightLiquid substanceMapsMediator of activation proteinMethodsNylonsOperative Surgical ProceduresPatientsPerformancePharmaceutical PreparationsPlayPreventionPropertyProteinsRecoveryResearchRoleSCID MiceSerpinsSilkSiteSkinSkin TissueSkin graftSkin repairSpine surgeryStaphylococcus aureus infectionSurgical Wound InfectionSurgical incisionsSurgical suturesTensile StrengthThickTimeTissuesToxic effectTranslatingTraumaTraumatic injuryVancomycinVisualizationWaterWound Infectionbiomaterial compatibilitychronic woundcombatdigital imaginghealingimmunoregulationimprovedin vivo evaluationinfrared microscopymethicillin resistant Staphylococcus aureusmortality riskmouse modelnanoparticlenanorodnovelnovel strategiespathogenphotoacoustic imagingporcine modelrepairedsealsealantskin woundsmall moleculesoft tissuetherapeutic proteintissue repairtissue traumatrauma surgeryultrasoundwound
项目摘要
Abstract
Effective approximation, repair, and healing of soft tissues is a significant challenge in trauma and most cases
require rapid, liquid-tight sealing of dermal tissue, which aids fast recovery of tissue biomechanical properties
and resists infections. Sutures and staples are commonly used but do not lead to immediate sealing, cause
significant tissue trauma, are prone to infection, leave characteristic scars and / or suffer from poor cosmesis,
especially in visible areas. Glues, including cyanoacrylate and fibrin, typically result in poor biomechanical
recoveries, can be cumbersome to apply, and / or suffer from formulation-dependent toxicities, which limits their
application only to superficial use in humans. Laser-activated nanoglues (LANGs) that use non-ionizing light,
integrate with tissue to rapidly provide a flight-tight seal, result in better biomechanical recoveries of soft tissues,
and demonstrate better cosmesis profiles are attractive alternatives for dermal sealing and repair. The efficacy
of LANGs, formulated using silk protein and near infrared light-absorbing nanoparticles (e.g. gold nanorods) or
dyes (e.g. indocyanine green), will be investigated for sealing full thickness wounds in live animals.
Biomechanical and biochemical characterization will be carried out in order to investigate the efficacy and
biocompatibility of LANGs compared to sutures and conventional glues; a combination of LANGs with sutures
will also be investigated as a combination approach for enhanced efficacy. In early stages of recovery, sealed
tissue is vulnerable and slow healing can lead to complications including surgical-site infections. Small-molecule
and protein therapeutics will be formulated with LANGs in order to accelerate closure and repair of dermal
incisional wounds particularly at earlier times. Efficacy of LANG sealing and other approximation methods (e.g.
sutures) will be visualized using hyperspectral and photoacoustic imaging of the wound site, and the
heterogeneity of tissue strain, visualized using digital image correlation, will be investigated as an indicator of
potential scarring. A comprehensive picture of LANG-facilitated tissue sealing will thus be generated using a
combination of imaging, biomechanical, and biochemical analyses. Wound infections affect up to 500,000 lives
each year, and are associated with a greater risk of death compared to patients without infection. LANGs will be
formulated with antibacterial drugs in order to simultaneously seal wounds, engender accelerated repair and
combat methicillin-resistant S. aureus (MRSA), which is the most common pathogen in community hospitals.
Our research will lead to novel, multifunctional LANGs that demonstrate high efficacy for sealing, delivery of
drugs for accelerating closure and early-stage repair, and combat infections. We anticipate that LANGs will be
translated particularly in applications where rapid dermal sealing and accelerated repair are desired, sutures and
staples have limited efficacy, infection control is critical and / or where there is a need for improved cosmesis
performance.
摘要
软组织的有效缝合、修复和愈合是创伤和大多数病例中的重大挑战,
这有助于快速恢复组织的生物力学特性
并且抵抗感染。通常使用缝线和斯台普斯,但不能立即闭合,原因是
显著组织创伤、易于感染、留下特征性疤痕和/或遭受不良美容,
尤其是在可见区域。胶水,包括氰基丙烯酸酯和纤维蛋白,通常会导致生物力学性能差,
回收,可能是繁琐的应用,和/或遭受制剂依赖性毒性,这限制了它们的应用。
仅用于人类的表面应用。使用非电离光的激光激活纳米胶(LANG),
与组织结合以快速提供飞行密封,导致软组织更好生物力学恢复,
并证明更好的美容外形是皮肤密封和修复的有吸引力的替代方案。疗效
使用丝蛋白和近红外光吸收纳米颗粒(例如金纳米棒)配制的LANG,或
将研究染料(例如吲哚菁绿色)用于密封活动物的全层伤口。
将进行生物力学和生物化学表征,以研究疗效和
LANG与缝线和传统胶水相比的生物相容性; LANG与缝线的组合
还将作为增强功效的组合方法进行研究。在恢复的早期阶段,
组织是脆弱的,并且缓慢的愈合可导致并发症,包括器官部位感染。小分子
和蛋白质治疗剂将与LANG一起配制,以加速真皮的闭合和修复。
尤其是早期的伤口。LANG凝闭和其他缝合方法(例如,
缝线)将使用伤口部位的高光谱和光声成像进行可视化,
将研究使用数字图像相关性可视化的组织应变的异质性,作为
可能留下疤痕因此,将使用LANG生成LANG促进的组织凝闭的全面图片,
成像、生物力学和生化分析的组合。伤口感染影响多达50万人的生命
与未感染的患者相比,这些患者的死亡风险更高。LANG将是
与抗菌药物一起配制,以便同时密封伤口,产生加速修复,
对抗耐甲氧西林S.金黄色葡萄球菌(MRSA),这是社区医院最常见的病原体。
我们的研究将导致新型的多功能LANG,其在密封、递送
加速闭合和早期修复的药物,以及对抗感染。我们预计,LANG将
特别是在需要快速皮肤密封和加速修复的应用中,
斯台普斯的有效性有限,感染控制至关重要和/或需要改善外观
性能
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kaushal Rege其他文献
Kaushal Rege的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kaushal Rege', 18)}}的其他基金
Near Infrared Light Activated Adhesives for Nerve Repair
用于神经修复的近红外光激活粘合剂
- 批准号:
10436799 - 财政年份:2021
- 资助金额:
$ 37.69万 - 项目类别:
Laser-Activated Nanoglues for the prevention and control of surgical site infections
激光激活纳米胶用于预防和控制手术部位感染
- 批准号:
10249234 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS
开发用于慢性伤口核酸输送的新型氨基糖苷聚合物和纳米颗粒
- 批准号:
10009545 - 财政年份:2020
- 资助金额:
$ 37.69万 - 项目类别:
Photothermal Nanocomposites for Tissue Repair
用于组织修复的光热纳米复合材料
- 批准号:
8945323 - 财政年份:2015
- 资助金额:
$ 37.69万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8602837 - 财政年份:2011
- 资助金额:
$ 37.69万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8212217 - 财政年份:2011
- 资助金额:
$ 37.69万 - 项目类别:
Engineering DNA Delivery Polymers using Combinatorial and Cheminformatics Methods
使用组合和化学信息学方法设计 DNA 递送聚合物
- 批准号:
8416396 - 财政年份:2011
- 资助金额:
$ 37.69万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 37.69万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 37.69万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
- 批准号:
10534864 - 财政年份:2023
- 资助金额:
$ 37.69万 - 项目类别: